CD44posCD49fhiCD133/2hi defines xenograft-initiating cells in estrogen receptor-negative breast cancer - Wikidata - awgldk - TriplyDB

CD44posCD49fhiCD133/2hi defines xenograft-initiating cells in estrogen receptor-negative breast cancer

CD44posCD49fhiCD133/2hi defines xenograft-initiating cells in estrogen receptor-negative breast cancer

http://www.wikidata.org/entity/Q28282860

about

Stem cell technology in breast cancer: current status and potential applications New Findings on Breast Cancer Stem Cells: A Review Increased Oxidative Stress as a Selective Anticancer Therapy Identifying and targeting tumor-initiating cells in the treatment of breast cancer Nanomedicine-Mediated Therapies to Target Breast Cancer Stem Cells CD133, Selectively Targeting the Root of Cancer Mammary gland stem cells and their application in breast cancer Cancer stem cells in basic science and in translational oncology: can we translate into clinical application?Nanog1 in NTERA-2 and recombinant NanogP8 from somatic cancer cells adopt multiple protein conformations and migrate at multiple M.W species Resistance to Taxanes in Triple-Negative Breast Cancer Associates with the Dynamics of a CD49f+ Tumor-Initiating Population.Regulated splicing of the α6 integrin cytoplasmic domain determines the fate of breast cancer stem cells.Cancer stem cell markers are enriched in normal tissue adjacent to triple negative breast cancer and inversely correlated with DNA repair deficiency.Apoptotic death of cancer stem cells for cancer therapy.Cell state plasticity, stem cells, EMT, and the generation of intra-tumoral heterogeneity.Challenging the roles of CD44 and lipolysis stimulated lipoprotein receptor in conveying Clostridium perfringens iota toxin cytotoxicity in breast cancer.Downregulation of Bmi1 in breast cancer stem cells suppresses tumor growth and proliferation.ABCG2, a novel antigen to sort luminal progenitors of BRCA1- breast cancer cells.Luteolin is a novel p90 ribosomal S6 kinase (RSK) inhibitor that suppresses Notch4 signaling by blocking the activation of Y-box binding protein-1 (YB-1)Cancer stem cells and side population cells in breast cancer and metastasis.p53, Stem Cells, and Reprogramming: Tumor Suppression beyond Guarding the Genome.Targeting cancer stem cells in solid tumors by vitamin D.Vitamin D compounds reduce mammosphere formation and decrease expression of putative stem cell markers in breast cancer.Upregulation of VEGF-A and CD24 gene expression by the tGLI1 transcription factor contributes to the aggressive behavior of breast cancer cells.Understanding cancer stem cell heterogeneity and plasticity.Development of a Fluorescent Reporter System to Delineate Cancer Stem Cells in Triple-Negative Breast Cancer.Stem cell-related markers in primary breast cancers and associated metastatic lesions.Potential for the embryonic morphogen Nodal as a prognostic and predictive biomarker in breast cancer Hypoxia-inducible factor 1α promotes primary tumor growth and tumor-initiating cell activity in breast cancer Identification of Distinct Breast Cancer Stem Cell Populations Based on Single-Cell Analyses of Functionally Enriched Stem and Progenitor Pools.Targeting the SIN3A-PF1 interaction inhibits epithelial to mesenchymal transition and maintenance of a stem cell phenotype in triple negative breast cancer.Development and characterization of two human triple-negative breast cancer cell lines with highly tumorigenic and metastatic capabilities.ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models.Basal-like breast cancer stem cells are sensitive to anti-DR5 mediated cytotoxicity.MiRNA Transcriptome Profiling of Spheroid-Enriched Cells with Cancer Stem Cell Properties in Human Breast MCF-7 Cell Line.GLI1 regulates a novel neuropilin-2/α6β1 integrin based autocrine pathway that contributes to breast cancer initiation.An integrated genomic approach identifies that the PI3K/AKT/FOXO pathway is involved in breast cancer tumor initiation.Cisplatin induces differentiation of breast cancer cells The significance of a Cripto-1 positive subpopulation of human melanoma cells exhibiting stem cell-like characteristics CD44 rs13347 C>T polymorphism predicts breast cancer risk and prognosis in Chinese populations.Strategies for isolating and enriching cancer stem cells: well begun is half done

P2860

Q26746223-F47ED959-6587-4358-8466-6F10E0712D0D Q26771894-7AED67F0-8A32-48EB-9981-6862F42CB0B7 Q26798210-8882E4BF-1EF2-4D27-B6B1-94208099FE8C Q26851827-349A36E2-012C-4F0E-90F4-CCD7C8FE9CD7 Q28066297-78DD43DE-BC21-4FC6-9C47-EB832F52B3EE Q28066353-B60DDF17-BCC8-4D4E-991E-5C0BF82C4DFC Q28075791-04468AF6-901A-41A0-806B-824E1C35E0CB Q28081844-0418919B-C7BA-4A49-8A24-FEE9A6E17671 Q28540510-210F7769-3550-4693-8A05-7205AA907D64 Q33659361-C2206E7B-0A9A-47FE-A443-CAA63B6A3B40 Q33685020-8DA296A5-9DD2-453D-97DF-24251D3C855E Q33741158-DAD4D749-2110-4994-AD6C-BD36DEAF3A6C Q33755766-0F863694-AF64-44A6-89EC-0534F07D3353 Q33767473-F5A58B11-879E-4D59-904C-DB5926E2058A Q33864348-72482BFC-07C8-4A6B-A79B-0B262EBB5D8D Q33888935-864FCFA8-DC8F-4974-ADFC-4FD2E7129C5C Q34252280-3B54A897-BA6E-40A1-BAA1-75210B1563F6 Q34675192-C490C567-0E50-4ABB-BFAF-74B682FB1352 Q35038054-BE9654E9-C384-4FDC-A6D3-92DECCD8303A Q35103179-9CCFDDAF-E617-4B44-B049-7C4E307AEBD6 Q35181108-2556FC79-0BAC-4A7A-83D9-2F3E58012A73 Q35181463-F39B7DBB-6EF7-4C64-9FFC-2BD0FBBEF920 Q35219125-C932AE57-E197-4DC6-904B-AB59CE9B1649 Q35796886-6FD4A356-E10E-422A-A8D4-CFC415791C0E Q35827788-E61170CC-9C0F-4CEE-A360-94722D668BEA Q36104759-A98FAEC3-BD2C-4AC9-A8E3-8BA5C7666546 Q36245363-D188557F-EA5D-4DAC-97D8-4D52DB5DEE15 Q36393103-00B29324-531E-4026-97B3-13B5DD22D72C Q36480693-E32B43FE-115F-400D-8D9C-007E1F8E8506 Q36544024-5E8367CB-CAC6-4F08-A5DE-4DE9070F02B5 Q36706840-6B6AB381-8BC2-4384-9435-1EBAF4C1893B Q36714784-D5162EC1-4942-4D5D-A196-F73A716B1745 Q36720866-06BE2256-47F2-4B18-9644-EE47583D0733 Q36727107-C308D0E6-1BC5-43E7-8F17-31B42BFEF3FF Q36771302-C4CBC76E-D942-4043-B854-C902FE8EA440 Q36771879-16D84911-9E29-46D8-AFD4-06A398E105A9 Q36893886-DF0DB993-8445-4ECD-822F-97C99F42A013 Q36906213-F94AFCE7-86D2-463D-9EE7-802ACC0E2528 Q36924387-0214C634-F83D-4FE4-9DA2-C7FC85059E9B Q37061915-B5ED0023-5E02-4538-83DE-F70909CB2E4D

P2860

CD44posCD49fhiCD133/2hi defines xenograft-initiating cells in estrogen receptor-negative breast cancer

http://www.wikidata.org/entity/Q28282860

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

CD44posCD49fhiCD133/2hi define ...... eceptor-negative breast cancer

@ast

CD44posCD49fhiCD133/2hi define ...... eceptor-negative breast cancer

@en

CD44posCD49fhiCD133/2hi define ...... eceptor-negative breast cancer

@nl

type

label

CD44posCD49fhiCD133/2hi define ...... eceptor-negative breast cancer

@ast

CD44posCD49fhiCD133/2hi define ...... eceptor-negative breast cancer

@en

CD44posCD49fhiCD133/2hi define ...... eceptor-negative breast cancer

@nl

prefLabel

CD44posCD49fhiCD133/2hi define ...... eceptor-negative breast cancer

@ast

CD44posCD49fhiCD133/2hi define ...... eceptor-negative breast cancer

@en

CD44posCD49fhiCD133/2hi define ...... eceptor-negative breast cancer

@nl

P1433

Q28282860-B73EBFA7-0D73-4DAA-8894-F7727A5271E5

P1476

Q28282860-117C41ED-5F53-4B28-8D7F-FC147AB57D5A

P2093

Q28282860-1B7DAE0F-186D-483B-894A-DF95F5205575

Q28282860-911CE391-401E-4AE4-B050-D8DBBC5475FF

Q28282860-AF171774-19E7-4173-ACA7-CFB107F0298D

Q28282860-DD52B2B9-0D3D-4255-84F7-251A655FF918

Q28282860-F72590E4-752A-438A-87F1-7DF2679B4B18

P2860

Q28282860-0BABEF89-C85D-4E15-B16F-8FC882FC61B3

Q28282860-1390359A-95C3-4856-832F-5503019FC658

Q28282860-13B0BBA9-899E-46FF-9BFB-D2A9C535167F

Q28282860-1A924E03-E95C-48DB-87DB-1FC56F182801

Q28282860-1A93D6ED-C74E-49A5-B736-9FBA706AA403

Q28282860-1E65E863-D5B1-4125-B3BE-89D9211C13E3

Q28282860-225254D5-4DBA-406C-B85B-605E6EDEFE85

Q28282860-273986F1-DF7D-4D8C-B167-FC7AD7E6E466

Q28282860-2B729F75-5618-49B5-93B6-8FA70CE5AFD6

Q28282860-30FB42BF-1CBE-4898-8546-331E0E62A571

P304

Q28282860-B6B1F94D-A101-4539-9FF7-B7B1B02DFE18

P31

Q28282860-0D90E8D3-B7FB-4B50-B2E3-773892D9D555

P3181

Q28282860-164C7B30-CA96-47D2-A8C8-8FC8E2523412

P356

Q28282860-AD091F91-04A0-40A0-83CC-E3934ED6CECF

P407

Q28282860-74F76333-D943-4CAC-8763-E6911C009917

P433

Q28282860-BB0CC809-2FF5-4B1A-97A6-74D4EAB763E3

P478

Q28282860-9AF6134F-4ECB-4DC8-B291-71FA02A0D9EA

P50

Q28282860-A37E1A73-9CC5-427A-916D-2900D3571E4F

P577

Q28282860-BD04E128-7F55-4B00-8AE7-FDBF3D5F7B29

P698

Q28282860-E2E8E5D9-3895-41B6-A648-BFEAED71671E

P921

Q28282860-093147B0-E6DF-46EB-8946-82627FBA4249

Q28282860-7481411E-C84B-43D8-A2FC-B6F928E8806C

P932

Q28282860-0E93B867-4254-47D9-BF91-8A4FF66EE951

P3181

P356

0008-5472.CAN-09-3619

P1433

Cancer Research

P1476

CD44posCD49fhiCD133/2hi define ...... eceptor-negative breast cancer

@en

P2093

Amy F Lin

http://www.w3.org/2001/XMLSchema#string

Barbara K Vonderhaar

http://www.w3.org/2001/XMLSchema#string

Erika Ginsburg

http://www.w3.org/2001/XMLSchema#string

Matthew J Meyer

http://www.w3.org/2001/XMLSchema#string

S Amal Hussnain

http://www.w3.org/2001/XMLSchema#string

P2860

Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction?

Core transcriptional regulatory circuitry in human embryonic stem cells

Bmi-1 promotes neural stem cell self-renewal and neural development but not mouse growth and survival by repressing the p16Ink4a and p19Arf senescence pathways.

Genome-scale DNA methylation maps of pluripotent and differentiated cells

High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs

Efficient tumour formation by single human melanoma cells

Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells

Prospective identification of tumorigenic breast cancer cells

Stem cells, cancer, and cancer stem cells

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

P304

4624-4633

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1215941

http://www.w3.org/2001/XMLSchema#string

P356

10.1158/0008-5472.CAN-09-3619

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

70

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-05-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20484027

http://www.w3.org/2001/XMLSchema#string

P921

estrogen-receptor negative breast cancer

P932

4129519

http://www.w3.org/2001/XMLSchema#string